MENU
GERN Geron Corp Chart, History Price & Graph
a developer of therapeutic products for cancer
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
GERN and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GERN | 1D Price Change % | ||
|---|---|---|---|---|
| GERN | 100% | -7.37% | ||
| SER - GERN | 63% Loosely correlated | -1.13% | ||
| SCPH - GERN | 37% Loosely correlated | -2.75% | ||
| ATYR - GERN | 36% Loosely correlated | -4.81% | ||
| XNCR - GERN | 36% Loosely correlated | -3.14% | ||
| NTLA - GERN | 36% Loosely correlated | -3.65% | ||
More | ||||
Groups containing GERN
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GERN | 1D Price Change % |
|---|---|---|
| GERN | 100% | -7.37% |
| GERN (2 stocks) | 54% Loosely correlated | -2.17% |
| drugs (265 stocks) | 32% Poorly correlated | +5.37% |
| cancer (87 stocks) | 31% Poorly correlated | +0.89% |
| biotechnology (248 stocks) | 31% Poorly correlated | +5.56% |
| therapeutics (57 stocks) | 31% Poorly correlated | +20.54% |